Amy Lyons

Senior Director, Communications at Flagship Pioneering

[Amy Lyons @AmyLyons22]

@amypoehler let's get Tom Holland to host @nbcsnl during #DyslexiaAwarenessMonth.

[susie @susieetweets]

tom holland tells amy poehler one of the main reasons he’s never hosed snl is because of his dyslexia and the fear of reading the cue cards on live tv

amy reminds tom that “people have fully been on drugs and hosted” 😭

i do love this moment where tom was vulnerable with amy

[Sherlock Biosciences @Sherlock_Bio]

Hear from our CEO @BryanDechairo on this podcast episode of PNC C-Speak by
@BosBizJournal @PNCBank.

Bryan shared his journey to @Sherlock_Bio, the importance of educating others on DNA, and our commitment to making diagnostics accessible to everyone.
https://t.co/bFk0dKzlj8

[Sherlock Biosciences @Sherlock_Bio]

Our colleague Peter Nguyen shares his why he’s passionate about Sherlock’s mission to make at-home diagnostic tests easier and faster for people to use.

[Amy Lyons @AmyLyons22]

Thank you @MassMEDICouncil for a great event!

[MassMEDIC @MassMEDICouncil]

A big thank you to everyone who filled out our #MedtechImpact Symposium Feedback Survey! With your feedback, we can't wait to make next year even better!

Shoutout to Amy Lyons, from @Sherlock_Bio for winning our survey raffle prize - a $100 Eddie V's gift card! 🎉

[Sherlock Biosciences @Sherlock_Bio]

At Sherlock, we are doing something that has never been done before.

Greg Dale, Our VP of Engineering and Product Development shares how Sherlock’s creative culture will bring affordable, accurate, rapid diagnostics everywhere they’re needed.

[Sherlock Biosciences @Sherlock_Bio]

Thank you @illuminaventure for this profile on Sherlock Biosciences, detailing how we are harnessing CRISPR, synthetic biology, and AI to create decentralized molecular diagnostic tests for the home and low resource settings.

https://t.co/RyXbHUzUrG

[Sherlock Biosciences @Sherlock_Bio]

Our Principal Scientist – Computational Design/AI @NatashaSeelam discusses The Future of Artificial Intelligence with @AuthorityMgzine. Natasha shares her journey in AI and insights on machine learning practices and data generation.

https://t.co/HGoQ2A5XdL

[Sherlock Biosciences @Sherlock_Bio]

Today we welcome Maurice Exner as Chief Scientific Officer. Maurice will lead our scientific research strategy to advance Sherlock's novel #CRISPR and synthetic biology-based chemistries to bring our innovative diagnostic technologies to the point-of-need.
https://t.co/WVcynBYHIF

[Bryan Dechairo @BryanDechairo]

On this #WorldHealthDay, I reflect on @Sherlock_Bio's mission to democratize and decentralize testing with novel #CRISPR diagnostics, so that people around the world have equitable access to healthcare.

Together, we can help make #HealthForAll a reality.

[Sherlock Biosciences @Sherlock_Bio]

Our CCO Julie Garlikov & CDO Karen Davies had a timely conversation w/ David Kemp on @MarketScale’s Highway to Health podcast about Sherlock's work to bring accessible, affordable, easy to use rapid at-home tests to the public.

https://t.co/SGD1iQ9LQs

#Testing #PublicHealth

[Amy Lyons @AmyLyons22]

It’s an honor to get to work on #innovation that will change the world and now we are one step closer. Read about our acquisition of @sensedx1 here.

[Sherlock Biosciences @Sherlock_Bio]

Today we take an exciting step to democratize & decentralize #diagnostics. With our #acquisition of @sensedx1, we will accelerate the development of powerful molecular #diagnostics to transform healthcare and empower consumers around the world. #Biotech
https://t.co/RkINBVUWhz

[Sherlock Biosciences @Sherlock_Bio]

At Sherlock, we wanted to create a space where we can all dream — a place for our talented individuals, amazing teams, and caring community to thrive and move forward in our mission to change global public health.

Welcome, everyone, to our new headquarters.

#HQ #biotech

[Sherlock Biosciences @Sherlock_Bio]

Our CEO @BryanDechairo spoke with @GenomeWeb's @tweetMadeleine about our newly licensed ambient temperature amplification tech from @HarvardTechXfer @wyssinstitute and how it enables us to create #diagnostic tests for #InfectiousDiseases #Biotech
https://t.co/iN8jwpG27T

[Sherlock Biosciences @Sherlock_Bio]

Thank you @globalergnet and @TalDimensions for naming Sherlock's Magnify Diversity, Equity, Engagement and Inclusion initiative one of the 2022 Top Ten Diversity Action Award winners! Congratulations to our team on earning this recognition for advancing #DEI in the workplace!

[Sherlock Biosciences @Sherlock_Bio]

On the two-year anniversary of The 221b Foundation, our Co-Founder @PardisSabeti joins the Board of Directors to support the foundation's mission to expand access to #CRISPR-based diagnostics globally.
#GlobalHealth
https://t.co/rUlgUXT1h9

[Sherlock Biosciences @Sherlock_Bio]

We're grateful to have contributed to the @wef report ESG Pulse Check: Getting the Basics Right for Start-ups and Venture Capital Firms! Check out the report: https://t.co/GH8tmHqikU

[Sherlock Biosciences @Sherlock_Bio]

Our CEO @BryanDechairo sat down with @minu_pr for #CRISPR Cuts Podcast to talk about Sherlock's advancements in CRISPR diagnostics to develop fast and accurate diagnostics for the point-of-need.

Listen here:
https://t.co/WqvZF5hsfZ

[Sherlock Biosciences @Sherlock_Bio]

Thank you, @shalinikantayya, for joining Sherlock's Magnify #DEI Group for a Q&A about the film @CodedBias!

"Algorithmic justice is the undone work of the civil rights movement." - Shalini Kantayya

#ArtificialIntelligence #EquitableAI
Take action here:
https://t.co/E93I2Ce0DO

[Sherlock Biosciences @Sherlock_Bio]

Our CEO @BryanDechairo spoke with @GrinsteinJ for his story in @GENbio, Sherlock Biosciences Is Cracking At-Home and Field Diagnostics.

Read about the #CRISPR advancements our team has made to bring our tests to the point-of-need:
https://t.co/8yvqFoZ6jL

[Bryan Dechairo @BryanDechairo]

Welcome to the @Sherlock_Bio team, Julie Garlikov! Julie is a #ConsumerHealth expert with a proven track record for scaling brands to drive growth. I'm excited to have her leading our path to commercialization!